Non-Substantive Change Request Justification

Justification for Program Changes – 0920-1313, exp. date 03/31/2026

Date: 04/10/2023

The details of the proposed revisions to this ICR are summarized here:

• CDC is requesting a nonmaterial/non-substantive change to Distribution of Traceable Opioid Material Kits across U.S. and International Laboratories survey questions (Attachments 5a and 5b). The requested change splits question 1 on both the domestic (Attachment 5a) and international (Attachment 5b) surveys into 2 questions for clarity. The vendor would like to use the responses received in the new question 1 of both surveys to determine which kits the requesting laboratory would like to order currently. The CDC program would like to know the summed answers to both new questions 1 and 2 to understand the TOM kits’ impact.

• This change will not impact the annual burden hours or the method of deployment for the survey.

Table 1 : Changes to the Domestic Survey (Att. 5a)

Page Number	Section	Proposed Revision
1	Testing Information Question 1	1. Which test kit(s) are you requesting? (provide quantity) Fentanyl Analog Screening (FAS) Quantity [___] FAS Version 1 Quantity [___] FAS Version 2 and 3 Quantity [___] FAS Version 4 Quantity [___] Emergent Drug Panel (EDP) Quantity [___] 2. Which test kit(s) have you previously received? (provide quantity) Fentanyl Analog Screening (FAS) Quantity [___] FAS Version 1 Quantity [___] FAS Version 2 and 3 Quantity [___] FAS Version 4 Quantity [___] Emergent Drug Panel (EDP) Quantity [___]
2	Testing Information Question 2	Update numbering to Question 3
2	Testing Information Question 3	Update numbering to Question 4
2	Testing Information Question 4	Update numbering to Question 5
2	Testing Information Question 5	Update numbering to Question 6
2	Testing Information Question 6	Update numbering to Question 7
2	Testing Information Question 7	Update numbering to Question 8

Table 2: Changes to the International Survey (Att. 5b)

Page Number	Section	Proposed Revision
1	Testing Information Question 1	1. Which test kit(s) are you requesting? (provide quantity) Fentanyl Analog Screening (FAS) Quantity [___] FAS Version 1 Quantity [___] FAS Version 2 and 3 Quantity [___] FAS Version 4 Quantity [___] 2. Which test kit(s) have you previously received? (provide quantity) Fentanyl Analog Screening (FAS) Quantity [___] FAS Version 1 Quantity [___] FAS Version 2 and 3 Quantity [___] FAS Version 4 Quantity [___]
2	Testing Information Question 2	Update numbering to Question 3
2	Testing Information Question 3	Update numbering to Question 4
2	Testing Information Question 4	Update numbering to Question 5
2	Testing Information Question 5	Update numbering to Question 6
2	Testing Information Question 6	Update numbering to Question 7
2	Testing Information Question 7	Update numbering to Question 8